Delivery Order SPE2DR25D2108-SPE2DR26F6RH1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,148.91 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector medication, with performance completion scheduled for November 26, 2025. This is a firm fixed-price delivery order issued under a non-compete, competitively awarded contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,789.92 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of October 31, 2025. This non-competitive delivery order represents a firm fixed-price purchase of specialty pharmaceutical products under the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,498.31 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed price delivery order, issued on December 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order valued at $35,711.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price, non-set-aside delivery order was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $9,570.07 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle for pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,405.33 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order was issued on September 25, 2025, with an ultimate completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $21,479.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector medication. This is a non-set-aside competitive award with an ultimate completion date of November 5, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be performed from the contractor's location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,775.33 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on October 22, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by October 23, 2025. The pharmaceutical product will be sourced and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as...
- SPE2DR25D2108Indefinite Delivery Contract
- SPE2DR25D2108-SPE2DR26F6RH1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,999.68 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed price, non-set-aside contract was executed on December 3, 2025, with an ultimate completion date of December 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supplier, regularly fulfills delivery orders through this prime IDC to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The Repatha auto-injector is a brand-name pharmaceutical product used for cardiovascular health management, reflecting AmerisourceBergen's extensive portfolio of specialty medications and medical devices supplied to federal healthcare programs. The company's federal contract history demonstrates consistent competitive awards across diverse therapeutic areas, positioning it as a key vendor for DLA's medical supply chain operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 12/2/25 |